On September 18, 2026, President Donald Trump shared significant news regarding the reduction of drug prices in the United States, marking major savings for Americans and state Medicaid programs.
1. Historic Price Decline:
Drug prices have experienced the largest decline in over 60 years, with monthly decreases noted throughout 2026.
2. Cost Savings:
This price drop is expected to save Americans over $600 billion, benefiting all 50 states, the District of Columbia, and Puerto Rico.
3. Most Favored Nation Pricing:
A new program involves 26 large drug manufacturers aligning U.S. prices with those of other developed nations, providing discounts directly to state Medicaid systems.
Consequently, $65 billion in Medicaid drug savings is projected over the next decade, aiding low-income families, seniors, and the disabled.
4. Wider Coverage:
The TrumpRX platform now includes more than 1,000 medications, enabling significant price reductions for various high-cost drugs, including GLP-1 drugs, fertility drugs, and others.
President Trump's initiatives in lowering prescription drug prices are designed to provide substantial financial relief to Americans, particularly through the Most Favored Nation program, with vital impacts on state Medicaid programs and overall healthcare affordability.
https://redstate.com/nick-arama/2026/09/18/most-favored-nation-drug-prices-n2207111
No comments:
Post a Comment